RNA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.68%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $31,187,816.48

Avidity Biosciences Insider Trading History Chart

Avidity Biosciences Share Price & Price History

^$25.58

▲ +1.47 (6.10%)

As of 04/11/2025 05:00 PM ET

Days: 30 | 90 | 365

Avidity Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2025	Kathleen P. Gallagher	Insider	Sell	5,875	$27.83	$163,501.25	50,554
3/20/2025	Michael F. MacLean	CFO	Sell	7,935	$31.06	$246,461.10	96,720
3/20/2025	Sarah Boyce	CEO	Sell	31,540	$31.06	$979,632.40	305,871
3/20/2025	Steven George Hughes	Insider	Sell	9,578	$31.06	$297,492.68	72,850
2/3/2025	Kathleen P. Gallagher	Insider	Sell	5,875	$32.16	$188,940.00	50,554
1/21/2025	Arthur A. Levin	Director	Sell	1,872	$28.60	$53,539.20	12,958
1/21/2025	Michael F. MacLean	CFO	Sell	3,287	$28.59	$93,975.33	104,655
1/21/2025	Sarah Boyce	CEO	Sell	10,397	$28.59	$297,250.23	337,411
1/21/2025	Teresa Mccarthy	Insider	Sell	2,959	$28.59	$84,597.81	104,908
12/18/2024	Michael F. MacLean	CFO	Sell	11,151	$32.66	$364,191.66	82,942
12/18/2024	Sarah Boyce	CEO	Sell	31,855	$32.66	$1,040,384.30	265,308
12/18/2024	W. Michael Flanagan	Insider	Sell	12,742	$32.66	$416,153.72	72,647
12/16/2024	Teresa Mccarthy	Insider	Sell	25,000	$33.26	$831,500.00	94,018
12/11/2024	W. Michael Flanagan	Insider	Sell	24,000	$35.77	$858,480.00	85,389
11/19/2024	Arthur A. Levin	Director	Sell	3,323	$42.12	$139,964.76	14,830
11/18/2024	Teresa Mccarthy	Insider	Sell	25,000	$41.14	$1,028,500.00	94,018
10/21/2024	Arthur A. Levin	Director	Sell	5,000	$46.63	$233,150.00	14,830
10/16/2024	Teresa Mccarthy	Insider	Sell	25,000	$48.52	$1,213,000.00	94,018
10/7/2024	Tamar Thompson	Director	Sell	30,000	$44.98	$1,349,400.00
9/23/2024	Michael F. MacLean	CFO	Sell	11,510	$44.00	$506,440.00	96,355
9/23/2024	Sarah Boyce	CEO	Sell	32,880	$44.00	$1,446,720.00	234,663
9/23/2024	Teresa Mccarthy	Insider	Sell	13,153	$44.00	$578,732.00	69,018
9/19/2024	Arthur A. Levin	Director	Sell	5,000	$45.73	$228,650.00	14,830
8/19/2024	Arthur A. Levin	Director	Sell	5,000	$45.19	$225,950.00	14,830
8/6/2024	Sarah Boyce	CEO	Sell	28,000	$43.35	$1,213,800.00	205,043
7/19/2024	Arthur A. Levin	Director	Sell	5,000	$45.01	$225,050.00	14,830
7/9/2024	Sarah Boyce	CEO	Sell	28,000	$39.93	$1,118,040.00	205,043
6/20/2024	Arthur A. Levin	Director	Sell	5,000	$37.59	$187,950.00	14,830
6/13/2024	Sarah Boyce	CEO	Sell	164,233	$40.08	$6,582,458.64	112,117
6/12/2024	Arthur A. Levin	Director	Sell	40,000	$35.07	$1,402,800.00	213,872
6/12/2024	Michael F. MacLean	CFO	Sell	104,245	$35.72	$3,723,631.40	44,093
6/4/2024	Sarah Boyce	CEO	Sell	28,000	$27.42	$767,760.00	112,117
5/20/2024	Arthur A. Levin	Director	Sell	5,000	$29.90	$149,500.00	14,830
5/14/2024	Michael F. MacLean	CFO	Sell	75,000	$28.28	$2,121,000.00	44,093
5/7/2024	Sarah Boyce	CEO	Sell	28,000	$25.54	$715,120.00	112,117
4/19/2024	Arthur A. Levin	Director	Sell	5,000	$22.82	$114,100.00	14,830
4/3/2024	Arthur A. Levin	Director	Sell	20,000	$27.11	$542,200.00	253,872
3/13/2024	Michael F. MacLean	CFO	Sell	40,000	$24.52	$980,800.00	44,093
3/12/2024	Arthur A. Levin	Director	Sell	27,641	$22.03	$608,931.23	14,830
3/12/2024	Sarah Boyce	CEO	Sell	28,000	$22.63	$633,640.00	112,117
3/8/2024	Sarah Boyce	CEO	Sell	84,000	$21.39	$1,796,760.00	112,117
1/22/2024	Arthur A. Levin	Director	Sell	1,859	$10.13	$18,831.67	17,471
1/22/2024	Michael F. MacLean	CFO	Sell	1,616	$10.13	$16,370.08	16,884
1/22/2024	Sarah Boyce	CEO	Sell	5,092	$10.13	$51,581.96	44,008
1/22/2024	W. Michael Flanagan	Insider	Sell	4,129	$10.13	$41,826.77	35,871
2/14/2023	Arthur A. Levin	Insider	Sell	10,000	$23.66	$236,600.00	19,330
2/3/2023	Sarah Boyce	CEO	Sell	3,221	$24.26	$78,141.46	53,352
2/1/2023	Sarah Boyce	CEO	Sell	900	$24.27	$21,843.00	53,352
1/12/2023	Arthur A. Levin	Insider	Sell	10,000	$22.00	$220,000.00	1,330
8/25/2022	Sarah Boyce	CEO	Sell	14,855	$23.07	$342,704.85
8/15/2022	Arthur A. Levin	Insider	Sell	62,498	$22.12	$1,382,455.76	1,330
8/15/2022	Sarah Boyce	CEO	Sell	100	$22.47	$2,247.00
8/12/2022	Arthur A. Levin	Insider	Sell	14,003	$22.00	$308,066.00	1,330

See Full Table

SEC Filings (Institutional Ownership Changes) for Avidity Biosciences (NASDAQ:RNA)

Institutional Buying and Selling by Quarter

Avidity Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/10/2025	Hennion & Walsh Asset Management Inc.	62,423	$1.84M	0.1%	-18.7%	0.052%
4/9/2025	Mirador Capital Partners LP	28,200	$0.83M	0.1%	+10.0%	0.023%
4/8/2025	Rhumbline Advisers	164,776	$4.86M	0.0%	+7.1%	0.137%
4/8/2025	Parallel Advisors LLC	1,705	$50K	0.0%	+43.3%	0.001%
4/7/2025	GAMMA Investing LLC	66,272	$1.96M	0.0%	+3,267.5%	0.055%
3/18/2025	California State Teachers Retirement System	84,552	$2.46M	0.0%	+9.2%	0.070%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	162,363	$4.72M	0.0%	N/A	0.136%
2/19/2025	GF Fund Management CO. LTD.	2,505	$73K	0.0%	N/A	0.002%
2/18/2025	Neo Ivy Capital Management	96,120	$2.80M	0.6%	+479.2%	0.081%
2/18/2025	Castleark Management LLC	70,620	$2.05M	0.1%	+23.7%	0.059%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	332,389	$9.67M	0.0%	-4.7%	0.279%
2/17/2025	Voloridge Investment Management LLC	191,550	$5.57M	0.0%	+235.7%	0.161%
2/17/2025	Waverly Advisors LLC	8,914	$0.26M	0.0%	N/A	0.007%
2/17/2025	Woodline Partners LP	865,820	$25.18M	0.2%	+27.7%	0.726%
2/17/2025	Squarepoint Ops LLC	172,875	$5.03M	0.0%	+6.8%	0.145%
2/17/2025	Twinbeech Capital LP	19,345	$0.56M	0.0%	N/A	0.016%
2/17/2025	Two Sigma Advisers LP	16,400	$0.48M	0.0%	-80.0%	0.014%
2/17/2025	Two Sigma Investments LP	132,560	$3.86M	0.0%	+1.9%	0.111%
2/17/2025	RTW Investments LP	7,932,870	$230.69M	3.5%	-2.5%	6.649%
2/17/2025	Rafferty Asset Management LLC	176,984	$5.15M	0.0%	-11.2%	0.148%
2/17/2025	Polar Capital Holdings Plc	1,271,891	$36.99M	0.2%	-17.5%	1.066%
2/17/2025	ProShare Advisors LLC	36,909	$1.07M	0.0%	+35.0%	0.031%
2/17/2025	Quantinno Capital Management LP	7,026	$0.20M	0.0%	+8.0%	0.006%
2/17/2025	MPM Bioimpact LLC	702,981	$20.44M	2.9%	+2.0%	0.589%
2/17/2025	Man Group plc	422,421	$12.28M	0.0%	-53.6%	0.354%
2/17/2025	Nuveen Asset Management LLC	352,498	$10.25M	0.0%	-66.7%	0.295%
2/17/2025	Nicholas Investment Partners LP	69,570	$2.02M	0.2%	N/A	0.058%
2/17/2025	Orbimed Advisors LLC	1,112,886	$32.36M	0.7%	-2.8%	0.933%
2/17/2025	Millennium Management LLC	23,941	$0.70M	0.0%	+29.2%	0.020%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	144,570	$4.21M	0.0%	-19.5%	0.121%
2/17/2025	Janus Henderson Group PLC	7,053,010	$205.13M	0.1%	+44.1%	5.911%
2/17/2025	Ensign Peak Advisors Inc	27,950	$0.81M	0.0%	+24.8%	0.023%
2/17/2025	FORA Capital LLC	18,787	$0.55M	0.1%	N/A	0.016%
2/17/2025	Deutsche Bank AG	193,586	$5.63M	0.0%	+18.6%	0.162%
2/17/2025	D. E. Shaw & Co. Inc.	558,969	$16.26M	0.0%	-49.6%	0.469%
2/17/2025	Driehaus Capital Management LLC	1,228,058	$35.71M	0.3%	+40.8%	1.029%
2/17/2025	Casdin Capital LLC	2,045,000	$59.47M	4.0%	-1.9%	1.714%
2/17/2025	Brevan Howard Capital Management LP	32,712	$0.95M	0.0%	+471.1%	0.027%
2/17/2025	Balyasny Asset Management L.P.	137,057	$3.99M	0.0%	-14.8%	0.115%
2/17/2025	Bank of America Corp DE	178,588	$5.19M	0.0%	-86.7%	0.150%
2/17/2025	BNP Paribas Financial Markets	21,608	$0.63M	0.0%	N/A	0.018%
2/17/2025	Ameriprise Financial Inc.	27,444	$0.80M	0.0%	+106.1%	0.023%
2/17/2025	Alethea Capital Management LLC	420,871	$12.24M	10.5%	-1.5%	0.353%
2/17/2025	Algert Global LLC	36,391	$1.06M	0.0%	-4.9%	0.031%
2/17/2025	Alyeska Investment Group L.P.	50,000	$1.45M	0.0%	-33.3%	0.042%
2/14/2025	Boxer Capital Management LLC	1,727,388	$50.23M	4.2%	N/A	1.448%
2/14/2025	Freestone Grove Partners LP	17,971	$0.52M	0.0%	N/A	0.015%
2/14/2025	Northern Trust Corp	1,079,434	$31.39M	0.0%	+11.2%	0.905%
2/14/2025	The Manufacturers Life Insurance Company	264,305	$7.69M	0.0%	+2.7%	0.222%
2/14/2025	Aquatic Capital Management LLC	60,641	$1.76M	0.0%	N/A	0.051%
2/14/2025	Voya Investment Management LLC	346,186	$10.07M	0.0%	+1.1%	0.290%
2/14/2025	Adage Capital Partners GP L.L.C.	2,751,944	$80.03M	0.1%	-10.6%	2.307%
2/14/2025	Price T Rowe Associates Inc. MD	11,042,823	$321.13M	0.0%	+3.8%	9.256%
2/14/2025	Silverarc Capital Management LLC	543,651	$15.81M	3.5%	+14.3%	0.456%
2/14/2025	Hsbc Holdings PLC	17,519	$0.51M	0.0%	+111.4%	0.015%
2/14/2025	Avoro Capital Advisors LLC	7,500,000	$218.10M	3.1%	+9.1%	6.286%
2/14/2025	Stifel Financial Corp	6,949	$0.20M	0.0%	-13.3%	0.006%
2/14/2025	TD Waterhouse Canada Inc.	1,000	$29K	0.0%	+646.3%	0.001%
2/14/2025	Teachers Retirement System of The State of Kentucky	33,161	$0.96M	0.0%	+10.7%	0.028%
2/14/2025	Tower Research Capital LLC TRC	26,029	$0.76M	0.0%	+2,044.1%	0.022%
2/14/2025	MetLife Investment Management LLC	66,795	$1.94M	0.0%	+7.1%	0.056%
2/14/2025	BI Asset Management Fondsmaeglerselskab A S	55,113	$1.60M	0.0%	N/A	0.046%
2/14/2025	Dimensional Fund Advisors LP	674,256	$19.61M	0.0%	+0.3%	0.565%
2/14/2025	First Trust Advisors LP	86,395	$2.51M	0.0%	+110.0%	0.072%
2/13/2025	CANADA LIFE ASSURANCE Co	19,013	$0.55M	0.0%	-6.7%	0.016%
2/13/2025	Marshall Wace LLP	162,863	$4.74M	0.0%	-10.6%	0.137%
2/13/2025	NewEdge Advisors LLC	19,427	$0.57M	0.0%	+7.8%	0.016%
2/13/2025	PEAK6 LLC	7,500	$0.22M	0.0%	N/A	0.006%
2/13/2025	Jump Financial LLC	95,575	$2.78M	0.1%	N/A	0.080%
2/13/2025	Guggenheim Capital LLC	33,887	$0.99M	0.0%	+3.1%	0.028%
2/13/2025	Walleye Capital LLC	91,935	$2.67M	0.0%	N/A	0.077%
2/13/2025	XTX Topco Ltd	8,889	$0.26M	0.0%	+47.2%	0.007%
2/13/2025	Mariner LLC	7,488	$0.22M	0.0%	-19.7%	0.006%
2/13/2025	Barclays PLC	250,011	$7.27M	0.0%	-2.2%	0.210%
2/13/2025	Summit Investment Advisors Inc.	11,611	$0.34M	0.3%	+6.1%	0.010%
2/13/2025	Raymond James Financial Inc.	198,907	$5.78M	0.0%	N/A	0.167%
2/13/2025	Renaissance Technologies LLC	211,200	$6.14M	0.0%	+48.8%	0.177%
2/13/2025	Legal & General Group Plc	102,100	$2.97M	0.0%	+7.3%	0.086%
2/13/2025	Invesco Ltd.	94,763	$2.76M	0.0%	-69.5%	0.079%
2/13/2025	FMR LLC	16,509,606	$480.10M	0.0%	-2.0%	13.838%
2/13/2025	Federated Hermes Inc.	1,577	$46K	0.0%	-94.2%	0.001%
2/13/2025	Finepoint Capital LP	391,300	$11.38M	0.7%	N/A	0.328%
2/13/2025	Envestnet Asset Management Inc.	33,132	$0.96M	0.0%	-10.6%	0.028%
2/13/2025	Dynamic Technology Lab Private Ltd	13,830	$0.40M	0.1%	N/A	0.012%
2/13/2025	Wells Fargo & Company MN	172,570	$5.02M	0.0%	-1.6%	0.145%
2/12/2025	ExodusPoint Capital Management LP	33,844	$0.98M	0.0%	N/A	0.028%
2/12/2025	Bryce Point Capital LLC	14,044	$0.41M	0.1%	N/A	0.012%
2/12/2025	Trexquant Investment LP	76,495	$2.22M	0.0%	+383.8%	0.064%
2/12/2025	Headlands Technologies LLC	2,062	$60K	0.0%	N/A	0.002%
2/12/2025	Geode Capital Management LLC	2,807,455	$82.83M	0.0%	+8.6%	2.353%
2/12/2025	Franklin Resources Inc.	63,399	$1.84M	0.0%	-13.2%	0.053%
2/12/2025	Alliancebernstein L.P.	127,770	$3.72M	0.0%	-25.1%	0.107%
2/12/2025	Wellington Management Group LLP	8,106,097	$235.73M	0.0%	+15.3%	6.743%
2/12/2025	Schroder Investment Management Group	61,480	$1.79M	0.0%	+99.7%	0.052%
2/12/2025	Orion Portfolio Solutions LLC	10,689	$0.31M	0.0%	-8.2%	0.009%
2/12/2025	Pictet Asset Management Holding SA	799,028	$23.24M	0.0%	+1.6%	0.670%
2/12/2025	Norges Bank	724,787	$21.08M	0.0%	N/A	0.607%
2/12/2025	JPMorgan Chase & Co.	450,144	$13.09M	0.0%	-3.6%	0.377%
2/12/2025	Artisan Partners Limited Partnership	1,015,251	$29.52M	0.0%	-23.6%	0.851%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	5,621	$0.17M	0.0%	-36.9%	0.005%

Data available starting January 2016

See Full Table

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

Today's Range

Now: $25.58

$23.66

$25.80

50 Day Range

MA: $30.31

$24.08

$35.11

52 Week Range

Now: $25.58

$21.51

$56.00

Volume

1,550,284 shs

Average Volume

1,390,460 shs

Market Capitalization

$3.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01

Who are the company insiders with the largest holdings of Avidity Biosciences?: Avidity Biosciences' top insider investors include:
Sarah Boyce (CEO)
Arthur A Levin (Director)
Teresa Mccarthy (Insider)
Michael F Maclean (CFO)
W Michael Flanagan (Insider)
Steven George Hughes (Insider)
Kathleen P Gallagher (Insider)
Tamar Thompson (Director)
Learn More about top insider investors at Avidity Biosciences.
Who are the major institutional investors of Avidity Biosciences?: Avidity Biosciences' top institutional investors include:
Rhumbline Advisers — 0.14%
GAMMA Investing LLC — 0.06%
Hennion & Walsh Asset Management Inc. — 0.05%
Mirador Capital Partners LP — 0.02%
Parallel Advisors LLC — 0.00%
Learn More about top institutional investors of Avidity Biosciences stock.
Which major investors are selling Avidity Biosciences stock?: During the previous quarter, RNA stock was sold by these institutional investors:
Hennion & Walsh Asset Management Inc.
Within the previous year, company insiders that have sold Avidity Biosciences company stock include:
Sarah Boyce (CEO)
Arthur A Levin (Director)
Teresa Mccarthy (Insider)
Michael F Maclean (CFO)
W Michael Flanagan (Insider)
Steven George Hughes (Insider)
Kathleen P Gallagher (Insider)
Tamar Thompson (Director)
Learn More investors selling Avidity Biosciences stock.
Which major investors are buying Avidity Biosciences stock?: Within the previous quarter, RNA stock was purchased by institutional investors including:
GAMMA Investing LLC
Rhumbline Advisers
Mirador Capital Partners LP
Parallel Advisors LLC